Plasmonic Nano-Aperture Imaging for Biological Nanoparticle Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting and analyzing circulating tumor exosomes (CTEs) face challenges due to their small size and complexity, leading to poor sensitivity and specificity, high background noise, and labor-intensive and costly protocols, which hinder early cancer detection and minimal residual disease monitoring.
Innovation Solution
The development of ultra near-field index modulated plasmonic nano-aperture label-free imaging techniques using high-density arrays of gold or silver nanodisks, which provide diffraction-limited resolution, higher surface sensitivity, and dense sampling capabilities, enabling the imaging and detection of CTEs and other biological nanoparticles.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If traditional optical microscopy is used to detect exosomes, then the equipment is simple and easy to operate, but the detection sensitivity is poor due to the small size of exosomes (30-150 nm)
Solution Approach 1:
The patent introduces plasmonic nanostructures (gold or silver nanodisks, nanoshells, or nanostars) as intermediary elements that interact with exosomes through localized surface plasmon resonance. These nanostructures serve as mediators that amplify the optical signal when exosomes bind to them, enabling detection of particles as small as 30-150 nm that are otherwise invisible to conventional optical microscopy. The plasmonic nanostructures convert the weak scattering signal from small exosomes into enhanced optical responses.
Solution Approach 2:
The patent utilizes changes in optical parameters (refractive index, scattering intensity, absorption) that occur when exosomes bind to plasmonic nanostructures. By monitoring these parameter changes through spectroscopic measurements or imaging, the system achieves high sensitivity detection. The binding event causes measurable shifts in the plasmon resonance conditions, allowing detection of single exosomes or small populations.
2Measurement precision
If nanoparticle tracking analysis (NTA) is used for exosome detection, then enumeration and size distribution can be obtained, but molecular specificity is lacking
Solution Approach 1:
The patent divides the detection process into separate functional modules: (1) exosome isolation/capture using plasmonic nanostructures with surface functionalization, (2) detection/characterization using plasmonic sensing, and (3) optional downstream analysis. This segmentation allows each module to be optimized independently and enables the system to provide both physical characterization (size, concentration) and molecular specificity through surface-functionalized capture elements.
Solution Approach 2:
The plasmonic sensing platform provides multiple functions in a single system: it can enumerate exosomes, measure size distribution, and provide molecular specificity through surface-functionalized capture. The same plasmonic nanostructure array can be used for both physical characterization and molecular identification, eliminating the need for separate NTA and molecular analysis instruments.
3Measurement precision
If fluorescence-based flow cytometry is used, then throughput is improved, but single unit sensitivity is lost due to averaging over many particles captured on microbeads
Solution Approach 1:
The patent transitions from conventional flow cytometry's single-file serial measurement to a parallel imaging approach using plasmonic nanostructure arrays. By arranging thousands of plasmonic sensing elements in a two-dimensional array and using wide-field optical imaging, the system can simultaneously detect and resolve individual exosomes bound to different nanostructures, achieving both single-particle sensitivity and high throughput through spatial multiplexing.
4Measurement precision
If exosome isolation and purification are performed using current protocols, then CTE enrichment is achieved, but the workflow becomes complex, labor-intensive, and time-consuming
Solution Approach 1:
The patent merges the isolation/enrichment function and the detection function into a single integrated platform. Plasmonic nanostructures are functionalized with capture elements (antibodies, aptamers, or other recognition molecules) that selectively bind CTEs. The same nanostructures that capture the exosomes also serve as the sensing elements for detection, eliminating the need for separate isolation and detection steps. This integration maintains high sensitivity while dramatically simplifying the workflow.
Solution Approach 2:
The plasmonic nanostructure array performs self-capture and self-detection. The surface-functionalized nanostructures automatically capture target exosomes from the sample, and the binding event itself generates the detection signal through plasmon resonance changes. No external labeling, amplification, or complex processing is required—the system uses the binding event directly as the measurement signal, enabling rapid, simple, and sensitive detection.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These techniques enable the precise imaging and detection of CTEs with high sensitivity and specificity, overcoming the limitations of existing methods by providing diffraction-limited resolution and dense sampling, facilitating early cancer detection and minimal residual disease monitoring.
Implementation Method 1
ultra near-field index modulated plasmonic nano-aperture label-free imaging techniques using high-density arrays of gold or silver nanodisks
Implementation Method 2
ultra near-field index modulated plasmonic nano-aperture label-free imaging techniques
Data Source
AI summary
Ultra near-field index modulated plasmonic nano-aperture label-free imaging methods and techniques are useful for imaging and detection of biological microparticles and nanoparticles such as circulating tumor exosomes (CTEs), bacteria and vimses. The methods and techniques utilize a high-density array of gold, silver, or gold/silver alloy nanodisks, in some cases on an undercut or invisible substrate. Given the relatively large nanodisk dimensions, the nanodisk array may feature a significantly blue-shifted LSPR extinction peak due to both far-field plasmonic coupling and substrate undercut. The ultra near-field imaging methods have the ability to image nanoparticles as small as 25 nm.